心脏骤停后爆发抑制中相同爆发波的回顾性视觉与定量评估
该回顾性研究纳入2013至2021年美国一家学术医学中心收治的593例心脏骤停幸存者,其中203例(34.2%)存在爆发抑制。视觉盲法评估按美国临床神经生理学会定义识别IBs,定量分析手动标记50对连续爆发波与爆发间期并计算相关系数。结果:80例(39.4%)检出IBs,定性IBs者无一例神经结局良好(76例死亡,4例无反应觉醒状态);无IBs的爆发抑制者中11/123(8.9%)达到CPC 1-2分。定量分析268次爆发抑制显示,仅分析爆发波前2秒时,较长爆发波、较长爆发间期和较高爆发波相关系数与死亡率相关;二分类logistic回归显示仅前2秒爆发波相关系数是死亡的独立脑电预测因子(校正OR 4.82,95%CI 1.21-8.42,p=0.009)。作者认为心脏骤停后72小时内IBs与不良结局强相关,定量分析纳入前2秒爆发波优于仅分析0.5-1秒。
要点
- 593例心脏骤停幸存者中203例(34.2%)出现爆发抑制,其中31例(15.3%)存活至出院。
- 爆发抑制者中80例(39.4%)检出相同爆发波(IBs),定性IBs者无一例神经结局良好:76例死亡、4例无反应觉醒状态。
- 无IBs的爆发抑制者中11/123(8.9%)达到Cerebral Performance Category 1-2分。
- 定量分析268次爆发抑制:仅分析爆发波前2秒时,较长爆发波、较长爆发间期和较高爆发波相关系数与死亡率相关。
- 二分类logistic回归显示,前2秒爆发波相关系数是死亡的唯一独立脑电预测因子(校正OR 4.82,95%CI 1.21-8.42,p=0.009)。
适用人群与场景
- 2013至2021年美国一家学术医学中心收治的心脏骤停幸存者,连续脑电图监测背景为爆发抑制。
诊断标准与关键阈值
- 爆发抑制的定性视觉评估按美国临床神经生理学会现行定义进行,评估者对包括结局在内的所有临床特征设盲。
- 在监测启动后0、12、24、48和72小时对脑电特征进行定性和定量评估。
- 定量评估手动标记50对连续爆发波与爆发间期,用相关系数评估爆发波/爆发间期的相似性。
研究设计与关键结果
- 回顾性分析593例心脏骤停患者,203例(34.2%)存在爆发抑制,31例(15.3%)存活至出院。
- 80例(占爆发抑制的39.4%)检出相同爆发波(IBs);定性IBs者无一例神经结局良好(76例死亡,4例无反应觉醒状态)。
- 无IBs的爆发抑制者中11/123(8.9%)Cerebral Performance Category评分为1-2分。
- 定量分析268次爆发抑制:仅允许分析爆发波前2秒时,死亡率与较长爆发波、较长爆发间期和较高爆发波相关系数(即爆发波彼此更相似)相关。
- 二分类logistic回归显示,死亡的唯一独立脑电预测因子是前2秒测量的爆发波相关系数(校正OR 4.82,95%CI 1.21-8.42,p=0.009)。
- 作者结论:心脏骤停后72小时内的IBs与不良结局强相关;定量分析纳入爆发波前2秒优于仅分析0.5-1秒。
证据类型、等级与局限
- 证据类型:单中心回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,心脏骤停后72小时内出现相同爆发波(IBs)与不良结局强相关。
- 作者认为,定量分析爆发波相似性时纳入前2秒优于仅分析0.5-1秒。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The objective of this study was to assess the prognostic significance of identical bursts (IBs) in cardiac arrest survivors with burst suppression on continuous electroencephalogram (cEEG) monitoring. Burst suppression with IBs is associated with poor neurological outcomes and mortality.
METHODS: We conducted a retrospective analysis of cardiac arrest survivors admitted to a US academic medical center between 2013 and 2021 who had an EEG background of burst suppression. EEG and clinical features were extracted from our institutional review board-approved repositories. EEG features were qualitatively and quantitatively rated at 0, 12, 24, 48, and 72 h following initiation of monitoring. Qualitative visual assessment occurred, blinded to all clinical features, including outcomes, and in accordance with the current American Clinical Neurophysiology Society definition. Quantitative assessment involved manual marking of 50 consecutive pairs of bursts and interburst intervals (IBIs) for analysis. Similarity of bursts/IBIs were assessed with correlation coefficients. The primary clinical outcome was survival to hospital discharge. Comparisons were performed between groups, and a multivariate model was generated for significant variables.
RESULTS: Of 593 cardiac arrest patients, 203 (34.2%) had burst suppression. Thirty-one (15.3%) patients with burst suppression survived. IBs were detected in 80 patients (39.4% of burst suppression). No patient with qualitatively identified IBs had a good neurological outcome (76 deceased, 4 in a state of unresponsive wakefulness). Whereas 11 of 123 (8.9%) with burst suppression without IB had Cerebral Performance Category scores of 1-2. Quantitative analysis of 268 instances of burst suppression demonstrated that mortality was associated with longer bursts, longer IBIs, and higher burst correlation coefficients (i.e., bursts that were more similar to each other) only when allowing analysis of the first 2 s of bursts. Binary logistic regression showed that the only independent EEG predictor of mortality was the burst correlation coefficient measured over 2 s (adjusted odds ratio 4.82 [95% confidence interval 1.21-8.42], p = 0.009).
CONCLUSIONS: Using a single-center US cohort, IBs within 72 h post cardiac arrest were strongly associated with poor outcomes. Quantitative analysis revealed that including the first 2 s of the bursts was superior to limiting the analysis to 0.5-1 s.
参考来源
- Fong MWK, Pu K, Beekman R, et al. Retrospective Visual and Quantitative Assessment of Burst Suppression With and Without Identical Bursts in Patients After Cardiac Arrest. Neurocrit Care. 2025. PMID: 39900751. doi:10.1007/s12028-024-02208-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。